SecBot SecBot
Insider Buy ·Filed Aug 24, 2026

ACOG

Alpha Cognition Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed2mo ago SEC0000912282-26-001153
Insider cluster: 1 insiders, $96K total
Actionable Insight • Neutral

The $96K director buy is too small relative to market cap to be a standalone catalyst. However, it adds to a pattern of insider buying ($519K over 30 days) and aligns with strong analyst sentiment. Monitor for additional insider purchases or a material catalyst (FDA update, partnership, earnings) to confirm the bullish thesis.

DirectionNeutral
Confidencemedium
Horizonweeks
Latest settled — T+20d ⚠ clustered
ACOG ▼ -8.21% at T+20d
NEUTRAL call -8.21% · α vs SPY -9.52% · entry $9.75 → $8.95
Next anchor: T+60d in 21d
Latest observation: T+43 -40.83% FF3 residual α
Entry = T+0 close
Aug 24, 2026
via day close
T+1d
0.00%
call 0.00% · α -0.32%
$9.75
settled 2mo ago
T+5d
-4.92%
call -4.92% · α -5.39%
$9.27
settled 8w ago
T+20d
-8.21%
call -8.21% · α -9.52%
$8.95
settled 5w ago
T+60d
Pending
in 21d

Price Chart

Loading chart...

Executive Summary

Director Robert James Wills purchased 10,000 shares of Alpha Cognition Inc. (ACOG) on the open market for $96,200 at $9.62 per share. This is a standalone conviction buy from a single director, not a multi-insider cluster, and represents approximately 0.05% of the company's $212M market cap — a trivial amount relative to company size. The purchase is too small to be a meaningful signal of material non-public information, but it does align with the company's strong analyst consensus (90% bullish) and recent insider buying activity ($519K over 30 days).

Key Financial Metrics

Direction
buying
Total Value
$96.2K
Insiders
1

Key Facts

  • Director Robert James Wills purchased 10,000 shares at $9.62 on 2026-08-21
  • Total purchase value: $96,200
  • Purchase represents ~0.05% of ACOG's $212M market cap
  • ACOG has 90% bullish analyst consensus (2 Strong Buy, 7 Buy, 1 Hold)
  • Recent insider activity (30d): 3 buys totaling $519K

Financial Impact

Director purchased $96,200 worth of stock — 0.05% of market cap

insider ownership

Risk Factors

  • Single director buy of $96K is trivial relative to $212M market cap — may be routine portfolio rebalancing
  • No material corporate catalyst (earnings, FDA, partnership) identified in this filing

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
90% bullish (10 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
INSIDER-BUY Data (Synthetic)0000912282-26-001153
7 reports for ACOG
Performance horizon
75% Hit rate @ T+5 3 of 4 directional calls Went positive at some point 3 of 4 best @ T+60▲ +50.08%May 19, 2026
Filters
Rows
Reports for ACOG — sortable, filterable
TypeNow
Sep 28, 2026
28d ago
Insider Buy
BULLISH ★ 5/10
$8.71 $8.98▲ +3.10%▲ +1.15%$8.30 (−4.71%)
Sep 23, 2026
4w ago
SC 13G
NEUTRAL ★ 3/10
$8.57 $8.70▲ +1.52%▲ +1.93%$8.30 (−3.15%)
Sep 16, 2026
5w ago
Insider Buy
BULLISH ★ 4/10
$8.85 $8.57▼ −3.16%▼ −3.76%$8.30 (−6.21%)
Aug 24, 2026
9w ago
Insider Buy
NEUTRAL ★ 3/10
$9.75 $9.27▼ −4.92%▼ −5.39%$8.30 (−14.87%)
May 19, 2026
22w ago
Insider Cluster
BULLISH ★ 5/10
$5.89 $5.94▲ +0.85%▼ −0.95%$8.30 (+40.92%)
Apr 20, 2026
27w ago
8-K
NEUTRAL ★ 3/10
$6.88 $6.20▼ −9.88%▼ −10.97%$8.30 (+20.64%)
Apr 14, 2026
27w ago
8-K
BULLISH ★ 7/10
$6.75 $6.99▲ +3.56%▲ +1.92%$8.30 (+22.96%)
Showing 7 of 7

US Market Status

Market Closed — Opens in 5h 38m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 24, 2026